Page 3 - Pliant Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pliant therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pliant Therapeutics Inc Today - Breaking & Trending Today

Pliant Therapeutics (NASDAQ:PLRX) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $36.00 target price on the stock. A number of other equities analysts also recently weighed in on the stock. Oppenheimer boosted their price […] ....

United States , British Columbia , Entrypoint Capital , Vanguard Group Inc , Pricet Rowe Associates Inc , Capital International Investors , Needham Company , Royal Bank , Redmile Group , Pliant Therapeutics Inc , Pliant Therapeutics , Free Report , Therapeutics Stock Down , Get Free Report , International Investors , Point Capital , Vanguard Group , Pliant Therapeutics Daily ,

Pliant Therapeutics (NASDAQ:PLRX) Given "Buy" Rating at HC Wainwright

HC Wainwright restated their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research note published on Wednesday morning, Benzinga reports. HC Wainwright currently has a $36.00 target price on the stock. Other equities research analysts also recently issued research reports about the company. Royal Bank of Canada cut their price […] ....

New York , United States , York State Common Retirement Fund , China Universal Asset Management Co , Barclays Plc , York Mellon Corp , Needham Company , Td Asset Management Inc , Pliant Therapeutics Inc , Royal Bank , Pliant Therapeutics , Free Report , Get Free Report , New York Mellon Corp , Management Inc , Universal Asset Management , New York State Common Retirement Fund , Pliant Therapeutics Daily ,

Pliant Therapeutics (NASDAQ:PLRX) Receives Buy Rating from HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a report issued on Wednesday morning, Benzinga reports. The brokerage currently has a $36.00 price target on the stock. A number of other analysts have also recently weighed in on the stock. Oppenheimer raised their target price on shares […] ....

United States , New York , Quest Partners , York State Common Retirement Fund , China Universal Asset Management Co , Pliant Therapeutics Company Profile , Needham Company , Proshare Advisors , Pliant Therapeutics Inc , Royal Bank , Pliant Therapeutics , Free Report , Get Free Report , Universal Asset Management , State Retirement System , Share Advisors , Pliant Therapeutics Daily ,

Pliant Therapeutics Announces Positive Topline Data from a

Pliant Therapeutics Announces Positive Topline Data from a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United States , Christopher Keenan , European Medicines Agency , Division Of Pulmonary , Drug Administration , Corporate Communications , Pliant Therapeutics Inc , Massachusetts General Hospital , Suggesting Potential Reversal , Treated Patients Demonstrated Improvements , Cough Severity , Fibrosis Biomarkers Across All Time Points , Cough Severity Visual Analog Scale , Chief Medical Officer , Sydney Montesi , Critical Care Medicine , Principal Investigator , Pliant Therapeutics , Fast Track Designation , Orphan Drug Designation , Private Securities Litigation Reform Act , Financial Condition , Annual Report , Quarterly Report , Media Contact , Investor Relations ,

Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis

Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Christopher Keenan , European Medicines Agency , Corporate Communications , Pliant Therapeutics Inc , Drug Administration , Division Of Pulmonary , Therapeutics Announces Positive Topline Data , Clinical Trial , Idiopathic Pulmonary , Massachusetts General Hospital , Suggesting Potential Reversal , Treated Patients Demonstrated Improvements , Cough Severity , Fibrosis Biomarkers Across All Time Points , Cough Severity Visual Analog Scale , Chief Medical Officer , Sydney Montesi , Critical Care Medicine , Principal Investigator , Pliant Therapeutics , Fast Track Designation , Orphan Drug Designation , Private Securities Litigation Reform Act , Financial Condition , Annual Report ,